• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT DUO M.R.I. IMPLANTABLE PORT, CHRONOFLEX DUAL-LUMEN, 9.5F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT DUO M.R.I. IMPLANTABLE PORT, CHRONOFLEX DUAL-LUMEN, 9.5F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 1829500
Device Problems Fluid/Blood Leak (1250); Difficult to Flush (1251); Suction Problem (2170); Material Protrusion/Extrusion (2979)
Patient Problem Extravasation (1842)
Event Date 03/01/2024
Event Type  Injury  
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.However, images were provided for review.The investigation of the reported event is currently underway.H10: d4 (expiration date: 07/2024).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that three months and two days post a port placement, the extravasation of fluoro contrast allegedly occurred around the reservoir.It was further reported that the silicone piece had allegedly dislodged from the plastic reservoir when the old reservoir was removed.Furthermore, there was an alleged difficulty in aspirating both the lumens over the last few chemo session.Moreover, the patient allegedly complained of stinging pain during infusions of the lateral reservoir and had a tissue plasminogen activator dwell in the pre-procedure bay with improvement in the medial lumen and still unable to aspirate the lateral lumen.Reportedly, the port was removed and replaced.The current status of the patient is unknown.
 
Event Description
It was reported that three months and two days post a port placement, the extravasation of fluoro contrast allegedly occurred around the reservoir.It was further reported that the silicone piece had allegedly dislodged from the plastic reservoir when the old reservoir was removed.Furthermore, there was an alleged difficulty in aspirating both the lumens over the last few chemo session.Moreover, the patient allegedly complained of stinging pain during infusions of the lateral reservoir and had a tissue plasminogen activator dwell in the pre-procedure bay with improvement in the medial lumen and still unable to aspirate the lateral lumen.Reportedly, the port was removed due to port site infection and replaced.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the sample was not returned for evaluation.However, three radiographic images were provided for review.The image shows leakage at the port-catheter interface and the silicone cuff (designed to secure the catheter to the port) was found ¿dislodged".Therefore, the investigation is confirmed for the reported material protrusion, leak, difficult to flush and suction issues.The definitive root cause could not be determined based upon available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: d4 (expiration date: 07/2024), g3, h6 (method).H11: b5, h6 (result, conclusion).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT DUO M.R.I. IMPLANTABLE PORT, CHRONOFLEX DUAL-LUMEN, 9.5F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key19102853
MDR Text Key340107624
Report Number3006260740-2024-01742
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027185
UDI-Public(01)00801741027185
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K090512
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1829500
Device Lot NumberREHP1314
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/18/2024
Initial Date FDA Received04/14/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age21 YR
Patient SexMale
-
-